This article forms part of Healthcare & Life Sciences Review: Switzerland February 2021, a comprehensive up-to-date country report on the Swiss…

Marcel Plattner, president of Swiss industry association vips discusses pricing, market access and innovation, as well as the continuing…

Susanne Hoeppner, GM of Astellas Switzerland and board member of vips, discusses her key priorities, the culture of Swiss pharma, and the…

Not all impactful innovation involves the development of new chemical or biological entities, and the value of such innovation must be recognized in…

Walter P. Hölzle, president of vips, discusses the current priorities of the association, the importance of innovation, and the challenges of the…